These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5600978)

  • 21. Duration of anticoagulant therapy for thromboembolism.
    Med Lett Drugs Ther; 1971 Aug; 13(17):70-1. PubMed ID: 5164090
    [No Abstract]   [Full Text] [Related]  

  • 22. Inherited fibrinogen abnormality causing thrombophilia.
    Egeberg O
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):176-87. PubMed ID: 5584950
    [No Abstract]   [Full Text] [Related]  

  • 23. Heparin induced thrombocytopenia: case reports and a prospective study.
    Romeril KR; Hickton CM; Hamer JW; Heaton DC
    N Z Med J; 1982 Apr; 95(706):267-9. PubMed ID: 6953369
    [No Abstract]   [Full Text] [Related]  

  • 24. [Test of platelet adhesiveness as a test of hypercoagulability].
    Vilalta-Bernet C; Company-Sala R; Balaguer-Vintró I; Casellas-Bernat A; Gilbert-Queraltó J
    Rev Esp Cardiol; 1966 Oct; 19(4):421-33. PubMed ID: 5995765
    [No Abstract]   [Full Text] [Related]  

  • 25. D-dimer testing and recurrent venous thromboembolism after unprovoked pulmonary embolism: A post-hoc analysis of the prolong extension study.
    Pengo V; Palareti G; Cosmi B; Legnani C; Tosetto A; Alatri A; Marzot F; Pegoraro C; Cucchini U; Iliceto S;
    Thromb Haemost; 2008 Oct; 100(4):718-21. PubMed ID: 18841301
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrinolytic activity and thromboembolism.
    Boyles PW
    Clin Pharmacol Ther; 1972; 13(4):534-8. PubMed ID: 4261283
    [No Abstract]   [Full Text] [Related]  

  • 27. Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy.
    Harker LA; Slichter SJ
    Thromb Diath Haemorrh; 1974 May; 31(2):188-203. PubMed ID: 4850635
    [No Abstract]   [Full Text] [Related]  

  • 28. beta-Thromboglobulin--a specific marker of in-vivo platelet release reaction.
    Zahavi J; Kakkar VV
    Thromb Haemost; 1980 Aug; 44(1):23-9. PubMed ID: 6158764
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic value of plasma fibrinogen in myocardial infarction.
    Gopal R; Saxena KK; Gupta B; Srivastava SS; Srivastava RK; Prasad DN
    J Postgrad Med; 1983 Oct; 29(4):233-5. PubMed ID: 6672181
    [No Abstract]   [Full Text] [Related]  

  • 30. [The phenomenon of oblique frequency distribution as exemplified by blood clotting factors. A neglected problem].
    Woszczyk J
    Pol Tyg Lek; 1974 Oct; 29(40):1693-6. PubMed ID: 4438152
    [No Abstract]   [Full Text] [Related]  

  • 31. A prospective study on cardiovascular events after acute pulmonary embolism.
    Becattini C; Agnelli G; Prandoni P; Silingardi M; Salvi R; Taliani MR; Poggio R; Imberti D; Ageno W; Pogliani E; Porro F; Casazza F
    Eur Heart J; 2005 Jan; 26(1):77-83. PubMed ID: 15615803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of myocardial infarct with anticoagulants. Comparative statistical studies in 658 patients].
    Weinreich J; Hörder MH; Tietjen K; Gaedeke U
    Dtsch Med Wochenschr; 1967 Jun; 92(22):1003-8. PubMed ID: 6024679
    [No Abstract]   [Full Text] [Related]  

  • 33. [On long-term anticoagulant therapy in coronary infarct].
    Müller WA
    Helv Med Acta; 1964 Sep; 31(3):238-56. PubMed ID: 5878391
    [No Abstract]   [Full Text] [Related]  

  • 34. [Myocardial infarction and pulmonary embolism in a 45 year-old woman with the prothrombin 20210A mutation--a case report].
    Wozakowska-Kapłon B; Szydziak-Zwierzyńska K
    Kardiol Pol; 2009 Feb; 67(2):162-7. PubMed ID: 19288379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thromboembolism problems in a surgical department].
    Storen EJ
    Tidsskr Nor Laegeforen; 1969 Feb; 89(3):165-71. PubMed ID: 5795435
    [No Abstract]   [Full Text] [Related]  

  • 36. Increase of endogenous antithrombolinase production in pulmonary embolism & myocardial infarct.
    KOVACS E
    Thromb Diath Haemorrh; 1957 Dec; 1(3-4):541-52. PubMed ID: 13581010
    [No Abstract]   [Full Text] [Related]  

  • 37. On significance of plasma fibrinogen level to assess severity of myocardial damage--an experimental study.
    Saxena KK; Gupta B; Srivastava VK; Kulshrestha VK; Prasad DN
    Indian J Exp Biol; 1979 Jun; 17(6):600-2. PubMed ID: 500143
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pathological-anatomical observations on the influence of anticoagulant therapy on the thromboembolic complications of acute coronary infarct].
    Lechner G
    Wien Klin Wochenschr; 1966 Feb; 78(5):87-90. PubMed ID: 5983035
    [No Abstract]   [Full Text] [Related]  

  • 39. Anticoagulant therapy following acute myocardial infarction. Part I. Incidence of and factors predisposing to thromboembolism associated with acute myocardial infarction.
    Genton E; Turpie AG
    Mod Concepts Cardiovasc Dis; 1983 Sep; 52(9):45-8. PubMed ID: 6633500
    [No Abstract]   [Full Text] [Related]  

  • 40. [Myocardial infarct and arterial peripheral blood circulation disorders and their clinical prognosis].
    Heine H; Schmidt H; Jahn E; Mach H
    Dtsch Gesundheitsw; 1972 Nov; 27(47):2209-12. PubMed ID: 4662680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.